Skip to main content
. 2021 Nov 30;2021:5534687. doi: 10.1155/2021/5534687

(b) Proportion of patients with SBM within 24 hours (relative risk and corresponding 95% Crls)

Elobixibat 10 mg
1.374 (0.529, 3.839) Linaclotide 0.5 mg
0.889 (0.390, 2.035) 0.645 (0.218, 1.800) Lubiprostone 48 μg
1.149 (0.433, 3.302) 0.836 (0.247, 2.829) 1.295 (0.453, 3.910) Lactulose 26 g
2.051 (1.277, 3.579) 1.493 (0.640, 3.516) 2.317 (1.259, 4.542) 1.789 (0.749, 4.308) Placebo